259 related articles for article (PubMed ID: 29745874)
41. Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis.
Shimizu K; Kobayashi T; Kano M; Hamaguchi Y; Takehara K; Matsushita T
J Dermatol; 2020 Jan; 47(1):64-68. PubMed ID: 31638280
[TBL] [Abstract][Full Text] [Related]
42. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
Kubeček O; Soukup T; Paulík A; Kopecký J
BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
[TBL] [Abstract][Full Text] [Related]
43. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population.
Mecoli CA; Igusa T; Chen M; Wang X; Albayda J; Paik JJ; Tiniakou E; Adler B; Richardson C; Kelly W; Danoff S; Mammen AL; Platz EA; Rosen A; Christopher-Stine L; Casciola-Rosen L; Shah AA
Arthritis Rheumatol; 2023 Apr; 75(4):620-629. PubMed ID: 35878018
[TBL] [Abstract][Full Text] [Related]
44. Ovoid palatal patch: a clue to anti-TIF1γ dermatomyositis.
Franciosi E; Blankenship K; Houk L; Rashighi M
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32332045
[TBL] [Abstract][Full Text] [Related]
45. Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis.
Zhang S; Chen YL; Liu CL; Xie JY; Sun BD; Liu DZ
Front Immunol; 2022; 13():757802. PubMed ID: 35185871
[TBL] [Abstract][Full Text] [Related]
46. Association of the serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis.
Li X; Bai J; Li S; Li M; Zeng X; Wang Q; Hu C
Clin Exp Rheumatol; 2023 Mar; 41(2):230-237. PubMed ID: 36226625
[TBL] [Abstract][Full Text] [Related]
47. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
[TBL] [Abstract][Full Text] [Related]
48. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
49. First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome.
Palterer B; Vitiello G; Cammelli D
Reumatismo; 2017 Aug; 69(2):75-77. PubMed ID: 28776361
[TBL] [Abstract][Full Text] [Related]
50. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.
Inoue M; Tanboon J; Hirakawa S; Komaki H; Fukushima T; Awano H; Tajima T; Yamazaki K; Hayashi R; Mori T; Shibuya K; Yamanoi T; Yoshimura H; Ogawa T; Katayama A; Sugai F; Nakayama Y; Yamaguchi S; Hayashi S; Noguchi S; Tachimori H; Okiyama N; Fujimoto M; Nishino I
JAMA Neurol; 2020 Jul; 77(7):872-877. PubMed ID: 32310254
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
Muro Y; Sugiura K; Akiyama M
Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
[TBL] [Abstract][Full Text] [Related]
52. Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients.
Kang EH; Kuwana M; Okazaki Y; Lee EY; Lee YJ; Lee EB; Song YW
Mod Rheumatol; 2014 Nov; 24(6):945-8. PubMed ID: 24670134
[TBL] [Abstract][Full Text] [Related]
53. Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis.
Fiorentino DF; Casciola-Rosen L
Clin Rev Allergy Immunol; 2022 Dec; 63(3):330-341. PubMed ID: 35593962
[TBL] [Abstract][Full Text] [Related]
54. Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study.
Dani L; Holmqvist M; Martínez MA; Trallero-Araguas E; Dastmalchi M; Svensson J; Labrador-Horrillo M; Selva-O'Callaghan A; Lundberg IE
Clin Exp Rheumatol; 2020; 38(1):67-73. PubMed ID: 31365334
[TBL] [Abstract][Full Text] [Related]
55. [Dermatomyositis-specific antibodies].
Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
[TBL] [Abstract][Full Text] [Related]
56. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies.
Wong VT; So H; Lam TT; Yip RM
Acta Neurol Scand; 2021 Feb; 143(2):131-139. PubMed ID: 32762037
[TBL] [Abstract][Full Text] [Related]
57. Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.
Mohassel P; Rosen P; Casciola-Rosen L; Pak K; Mammen AL
Arthritis Rheumatol; 2015 Jan; 67(1):266-72. PubMed ID: 25186009
[TBL] [Abstract][Full Text] [Related]
58. A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood.
Agrawal U; Sondhi M; Zamora Smith A; Nida SS; Umer S; Hayat S; Muzaffar K
J Investig Med High Impact Case Rep; 2024; 12():23247096241263065. PubMed ID: 38904327
[TBL] [Abstract][Full Text] [Related]
59. Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report.
Xie JJ; Li B; Xu R; Du XZ; He JZ
BMC Pulm Med; 2021 Jun; 21(1):204. PubMed ID: 34193090
[TBL] [Abstract][Full Text] [Related]
60. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
